Generalized Anxiety Disorder Clinical Trial
— PACEROfficial title:
Patient-centered Treatment of Anxiety After Low-Risk Chest Pain in the Emergency Room
Verified date | June 2024 |
Source | Indiana University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this research is to compare the benefits and risks of three anxiety treatments that are pragmatic, graduated in the level of resource intensity, and have demonstrated efficacy and feasibility for real world adoption.
Status | Enrolling by invitation |
Enrollment | 375 |
Est. completion date | December 31, 2025 |
Est. primary completion date | June 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adult emergency department (ED) patients (=18yoa) presenting to the ED - Within 1 week of ED presentation if discharged at time of screening. - Chief complaint of chest pain or similar chief complaint leading to a standard of care diagnostic protocol to rule out possible acute coronary syndrome. - HEART Score of 0-3 indicating Major Adverse Cardiac Events (MACE) risk equivalent to =2% - "Functionally" low risk status - (moderate HEART score of 4-6) plus diagnostic protocol evaluation with at least two serial normal troponins spaced at least six hours apart with or without cardiovascular stress testing in the observation unit. - Moderate to severe anxiety as defined by a GAD-7 score = 8 or a PHQ panic screener score = 2 - Expected to be discharged from the ED or only undergo observation <24 hours. Exclusion Criteria: - > 1 week from ED discharge - Traumatic reason for chest pain - Those admitted to the hospital (inpatient status) as part of their ED presentation (those placed in the observation unit for planned observation less than <24 hours are eligible) - Active psychosis or behavioral issues requiring psychiatric monitoring or consultation of psychiatry for psychosis, schizophrenia, or suicidal ideation - Hemodynamic instability as assessed by the treating provider - Issues likely to affect follow up, including prisoners and homelessness - Inability to understand and speak English to participate in telehealth therapy sessions and peer support. |
Country | Name | City | State |
---|---|---|---|
United States | Indiana University Health West Hospital | Avon | Indiana |
United States | Indiana University Health North Hospital | Carmel | Indiana |
United States | Indiana University Health Saxony Hospital | Fishers | Indiana |
United States | Indiana University Health Methodist Hospital | Indianapolis | Indiana |
United States | Indiana University Health Ball Memorial Hosptial | Muncie | Indiana |
Lead Sponsor | Collaborator |
---|---|
Indiana University | Patient-Centered Outcomes Research Institute |
United States,
Aikens JE, Michael E, Levin T, Myers TC, Lowry E, McCracken LM. Cardiac exposure history as a determinant of symptoms and emergency department utilization in noncardiac chest pain patients. J Behav Med. 1999 Dec;22(6):605-17. doi: 10.1023/a:1018745813664. — View Citation
Ali S, Rhodes L, Moreea O, McMillan D, Gilbody S, Leach C, Lucock M, Lutz W, Delgadillo J. How durable is the effect of low intensity CBT for depression and anxiety? Remission and relapse in a longitudinal cohort study. Behav Res Ther. 2017 Jul;94:1-8. doi: 10.1016/j.brat.2017.04.006. Epub 2017 Apr 18. — View Citation
Backus BE, Six AJ, Kelder JC, Bosschaert MA, Mast EG, Mosterd A, Veldkamp RF, Wardeh AJ, Tio R, Braam R, Monnink SH, van Tooren R, Mast TP, van den Akker F, Cramer MJ, Poldervaart JM, Hoes AW, Doevendans PA. A prospective validation of the HEART score for chest pain patients at the emergency department. Int J Cardiol. 2013 Oct 3;168(3):2153-8. doi: 10.1016/j.ijcard.2013.01.255. Epub 2013 Mar 7. — View Citation
Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B (Methodological) 1995;57:289-300.
Bushey MA, Kroenke K, Weiner J, Porter B, Evans E, Baye F, Lourens S, Weitlauf S. Telecare management of pain and mood symptoms: Adherence, utility, and patient satisfaction. J Telemed Telecare. 2020 Dec;26(10):619-626. doi: 10.1177/1357633X19856156. Epub 2019 Jun 20. — View Citation
Butterfoss FD, Goodman RM, Wandersman A. Community coalitions for prevention and health promotion. Health Educ Res. 1993 Sep;8(3):315-30. doi: 10.1093/her/8.3.315. No abstract available. — View Citation
Cape J, Whittington C, Buszewicz M, Wallace P, Underwood L. Brief psychological therapies for anxiety and depression in primary care: meta-analysis and meta-regression. BMC Med. 2010 Jun 25;8:38. doi: 10.1186/1741-7015-8-38. — View Citation
Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. New York: Academic Press; 1988.
Craske MG, Stein MB, Sullivan G, Sherbourne C, Bystritsky A, Rose RD, Lang AJ, Welch S, Campbell-Sills L, Golinelli D, Roy-Byrne P. Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary care. Arch Gen Psychiatry. 2011 Apr;68(4):378-88. doi: 10.1001/archgenpsychiatry.2011.25. — View Citation
Demiryoguran NS, Karcioglu O, Topacoglu H, Kiyan S, Ozbay D, Onur E, Korkmaz T, Demir OF. Anxiety disorder in patients with non-specific chest pain in the emergency setting. Emerg Med J. 2006 Feb;23(2):99-102. doi: 10.1136/emj.2005.025163. — View Citation
Dube P, Kurt K, Bair MJ, Theobald D, Williams LS. The p4 screener: evaluation of a brief measure for assessing potential suicide risk in 2 randomized effectiveness trials of primary care and oncology patients. Prim Care Companion J Clin Psychiatry. 2010;12(6):PCC.10m00978. doi: 10.4088/PCC.10m00978blu. — View Citation
Dugas MJ, Robichaud M. Cognitive-Behavioral Treatment for Generalized Anxiety Disorder: From Science to Practice. New York. : Routledge; 2007.
Eich HS, Kriston L, Schramm E, Bailer J. The German version of the helping alliance questionnaire: psychometric properties in patients with persistent depressive disorder. BMC Psychiatry. 2018 Apr 23;18(1):107. doi: 10.1186/s12888-018-1697-8. — View Citation
Eken C, Oktay C, Bacanli A, Gulen B, Koparan C, Ugras SS, Cete Y. Anxiety and depressive disorders in patients presenting with chest pain to the emergency department: a comparison between cardiac and non-cardiac origin. J Emerg Med. 2010 Aug;39(2):144-50. doi: 10.1016/j.jemermed.2007.11.087. Epub 2008 Aug 23. — View Citation
Eslick GD, Talley NJ. Natural history and predictors of outcome for non-cardiac chest pain: a prospective 4-year cohort study. Neurogastroenterol Motil. 2008 Sep;20(9):989-97. doi: 10.1111/j.1365-2982.2008.01133.x. Epub 2008 May 6. — View Citation
Foldes-Busque G, Marchand A, Chauny JM, Poitras J, Diodati J, Denis I, Lessard MJ, Pelland ME, Fleet R. Unexplained chest pain in the ED: could it be panic? Am J Emerg Med. 2011 Sep;29(7):743-51. doi: 10.1016/j.ajem.2010.02.021. Epub 2010 May 1. — View Citation
Granner ML, Sharpe PA. Evaluating community coalition characteristics and functioning: a summary of measurement tools. Health Educ Res. 2004 Oct;19(5):514-32. doi: 10.1093/her/cyg056. Epub 2004 May 17. — View Citation
Hunot V, Churchill R, Silva de Lima M, Teixeira V. Psychological therapies for generalised anxiety disorder. Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD001848. doi: 10.1002/14651858.CD001848.pub4. — View Citation
Kamper SJ, Maher CG, Mackay G. Global rating of change scales: a review of strengths and weaknesses and considerations for design. J Man Manip Ther. 2009;17(3):163-70. doi: 10.1179/jmt.2009.17.3.163. — View Citation
Kisely SR, Campbell LA, Yelland MJ, Paydar A. Psychological interventions for symptomatic management of non-specific chest pain in patients with normal coronary anatomy. Cochrane Database Syst Rev. 2012 Jun 13;(6):CD004101. doi: 10.1002/14651858.CD004101.pub4. — View Citation
Kline JA, Shapiro NI, Jones AE, Hernandez J, Hogg MM, Troyer J, Nelson RD. Outcomes and radiation exposure of emergency department patients with chest pain and shortness of breath and ultralow pretest probability: a multicenter study. Ann Emerg Med. 2014 Mar;63(3):281-8. doi: 10.1016/j.annemergmed.2013.09.009. Epub 2013 Oct 10. — View Citation
Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, Kroenke K, Bair MJ, Noorbaloochi S. Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial. JAMA. 2018 Mar 6;319(9):872-882. doi: 10.1001/jama.2018.0899. — View Citation
Kroenke K, Baye F, Lourens SG, Evans E, Weitlauf S, McCalley S, Porter B, Matthias MS, Bair MJ. Automated Self-management (ASM) vs. ASM-Enhanced Collaborative Care for Chronic Pain and Mood Symptoms: the CAMMPS Randomized Clinical Trial. J Gen Intern Med. 2019 Sep;34(9):1806-1814. doi: 10.1007/s11606-019-05121-4. Epub 2019 Jun 21. — View Citation
Kroenke K, Evans E, Weitlauf S, McCalley S, Porter B, Williams T, Baye F, Lourens SG, Matthias MS, Bair MJ. Comprehensive vs. Assisted Management of Mood and Pain Symptoms (CAMMPS) trial: Study design and sample characteristics. Contemp Clin Trials. 2018 Jan;64:179-187. doi: 10.1016/j.cct.2017.10.006. Epub 2017 Oct 12. — View Citation
Kroenke K, Krebs E, Wu J, Bair MJ, Damush T, Chumbler N, York T, Weitlauf S, McCalley S, Evans E, Barnd J, Yu Z. Stepped Care to Optimize Pain care Effectiveness (SCOPE) trial study design and sample characteristics. Contemp Clin Trials. 2013 Mar;34(2):270-81. doi: 10.1016/j.cct.2012.11.008. Epub 2012 Dec 8. — View Citation
Kroenke K, Krebs EE, Wu J, Yu Z, Chumbler NR, Bair MJ. Telecare collaborative management of chronic pain in primary care: a randomized clinical trial. JAMA. 2014 Jul 16;312(3):240-8. doi: 10.1001/jama.2014.7689. — View Citation
Kroenke K, Spitzer RL, Williams JB, Lowe B. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345-59. doi: 10.1016/j.genhosppsych.2010.03.006. Epub 2010 May 7. — View Citation
Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007 Mar 6;146(5):317-25. doi: 10.7326/0003-4819-146-5-200703060-00004. — View Citation
Leon AC, Olfson M, Portera L, Farber L, Sheehan DV. Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med. 1997;27(2):93-105. doi: 10.2190/T8EM-C8YH-373N-1UWD. — View Citation
Leon AC, Shear MK, Portera L, Klerman GL. Assessing impairment in patients with panic disorder: the Sheehan Disability Scale. Soc Psychiatry Psychiatr Epidemiol. 1992 Mar;27(2):78-82. doi: 10.1007/BF00788510. — View Citation
Lowe B, Grafe K, Zipfel S, Spitzer RL, Herrmann-Lingen C, Witte S, Herzog W. Detecting panic disorder in medical and psychosomatic outpatients: comparative validation of the Hospital Anxiety and Depression Scale, the Patient Health Questionnaire, a screening question, and physicians' diagnosis. J Psychosom Res. 2003 Dec;55(6):515-9. doi: 10.1016/s0022-3999(03)00072-2. — View Citation
Mewton L, Wong N, Andrews G. The effectiveness of internet cognitive behavioural therapy for generalized anxiety disorder in clinical practice. Depress Anxiety. 2012 Oct;29(10):843-9. doi: 10.1002/da.21995. Epub 2012 Sep 4. — View Citation
Mitchell AJ, Yadegarfar M, Gill J, Stubbs B. Case finding and screening clinical utility of the Patient Health Questionnaire (PHQ-9 and PHQ-2) for depression in primary care: a diagnostic meta-analysis of 40 studies. BJPsych Open. 2016 Mar 9;2(2):127-138. doi: 10.1192/bjpo.bp.115.001685. eCollection 2016 Mar. — View Citation
Musey PI Jr, Patel R, Fry C, Jimenez G, Koene R, Kline JA. Anxiety Associated With Increased Risk for Emergency Department Recidivism in Patients With Low-Risk Chest Pain. Am J Cardiol. 2018 Oct 1;122(7):1133-1141. doi: 10.1016/j.amjcard.2018.06.044. Epub 2018 Jul 5. — View Citation
Muthen LK, Muthen BO. Mplus User's Guide. Eighth Edition. Los Angeles, CA: Muthen & Muthen; 1998-2017.
Napoli AM, Baird J, Tran S, Wang J. Low Adverse Event Rates But High Emergency Department Utilization in Chest Pain Patients Treated in an Emergency Department Observation Unit. Crit Pathw Cardiol. 2017 Mar;16(1):15-21. doi: 10.1097/HPC.0000000000000099. — View Citation
Nault Connors JD, Prittie A, Musey PI. Why an Algorithmic "Rule-Out MI" Order Set Is Necessary But Not Sufficient Care for Chest Pain in the Emergency Department Setting. J Patient Exp. 2020 Oct;7(5):685-687. doi: 10.1177/2374373519881279. Epub 2019 Oct 15. No abstract available. — View Citation
Perini S, Titov N, Andrews G. Clinician-assisted Internet-based treatment is effective for depression: randomized controlled trial. Aust N Z J Psychiatry. 2009 Jun;43(6):571-8. doi: 10.1080/00048670902873722. — View Citation
Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016 Mar-Apr;39:24-31. doi: 10.1016/j.genhosppsych.2015.11.005. Epub 2015 Nov 18. — View Citation
Prins A, Ouimette P, Kimerling R. The primary care PTSD screen (PC-PTSD): development and operating characteristics. Primary Care Psychiatry 2003;9:9-14.
Reichheld FF, Markey R. The Ultimate Question 2.0: How Net Promoter Companies Thrive in a Customer-driven World: Harvard Business Press; 2011.
Reichheld FF. The one number you need to grow. Harv Bus Rev. 2003 Dec;81(12):46-54, 124. — View Citation
Richards DA, Suckling R. Improving access to psychological therapies: phase IV prospective cohort study. Br J Clin Psychol. 2009 Nov;48(Pt 4):377-96. doi: 10.1348/014466509X405178. Epub 2009 Feb 9. — View Citation
Rodriguez BF, Weisberg RB, Pagano ME, Machan JT, Culpepper L, Keller MB. Frequency and patterns of psychiatric comorbidity in a sample of primary care patients with anxiety disorders. Compr Psychiatry. 2004 Mar-Apr;45(2):129-37. doi: 10.1016/j.comppsych.2003.09.005. — View Citation
Rui P, Kang K. National Hospital Ambulatory Medical Care Survey: 2015 Emergency Department Summary Tables. CDC, US Centers for Disease Control and Prevention; 2015:34.
Schwarzer R, Born A. Optimistic self-beliefs: Assessment of general perceived self-efficacy in thirteen cultures. World Psychology 1997;3:177-90.
Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999 Nov 10;282(18):1737-44. doi: 10.1001/jama.282.18.1737. — View Citation
Webster R, Norman P, Goodacre S, Thompson AR, McEachan RR. Illness representations, psychological distress and non-cardiac chest pain in patients attending an emergency department. Psychol Health. 2014;29(11):1265-82. doi: 10.1080/08870446.2014.923885. Epub 2014 Jun 18. — View Citation
Zijlema WL, Stolk RP, Lowe B, Rief W; BioSHaRE; White PD, Rosmalen JG. How to assess common somatic symptoms in large-scale studies: a systematic review of questionnaires. J Psychosom Res. 2013 Jun;74(6):459-68. doi: 10.1016/j.jpsychores.2013.03.093. Epub 2013 Apr 24. — View Citation
* Note: There are 49 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Anxiety Symptoms | General Anxiety Disorder-7 scale score adjusted for baseline. 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety | 3 months after enrollment | |
Primary | Anxiety Symptoms | General Anxiety Disorder-7 scale score adjusted for baseline. 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety | 6 months after enrollment | |
Primary | Anxiety Symptoms | General Anxiety Disorder-7 scale score adjusted for baseline. 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety | 9 months after enrollment | |
Primary | Anxiety Symptoms | General Anxiety Disorder-7 scale score adjusted for baseline. 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety | 12 months after enrollment | |
Secondary | Panic Symptoms | PHQ Panic Screener adjusted for baseline | 3 months after enrollment | |
Secondary | Panic Symptoms | PHQ Panic Screener adjusted for baseline | 6 months after enrollment | |
Secondary | Panic Symptoms | PHQ Panic Screener adjusted for baseline | 9 months after enrollment | |
Secondary | Panic Symptoms | PHQ Panic Screener adjusted for baseline | 12 months after enrollment | |
Secondary | Chest Pain | Chest pain frequency as adjusted for baseline | 3 months after enrollment | |
Secondary | Chest Pain | Chest pain frequency as adjusted for baseline | 6 months after enrollment | |
Secondary | Chest Pain | Chest pain frequency as adjusted for baseline | 9 months after enrollment | |
Secondary | Chest Pain | Chest pain frequency as adjusted for baseline | 12 months after enrollment | |
Secondary | Physical Symptoms | PHQ-15 total score as adjusted for baseline | 3 months after enrollment | |
Secondary | Physical Symptoms | PHQ-15 total score as adjusted for baseline | 6 months after enrollment | |
Secondary | Physical Symptoms | PHQ-15 total score as adjusted for baseline | 9 months after enrollment | |
Secondary | Physical Symptoms | PHQ-15 total score as adjusted for baseline | 12 months after enrollment | |
Secondary | Depression symptoms | PHQ-8 total score as adjusted for baseline | 3 months after enrollment | |
Secondary | Depression symptoms | PHQ-8 total score as adjusted for baseline | 6 months after enrollment | |
Secondary | Depression symptoms | PHQ-8 total score as adjusted for baseline | 9 months after enrollment | |
Secondary | Depression symptoms | PHQ-8 total score as adjusted for baseline | 12 months after enrollment | |
Secondary | Work/family/social functioning | Sheehan Disability scale as adjusted for baseline | 3 months after enrollment | |
Secondary | Work/family/social functioning | Sheehan Disability scale as adjusted for baseline | 6 months after enrollment | |
Secondary | Work/family/social functioning | Sheehan Disability scale as adjusted for baseline | 9 months after enrollment | |
Secondary | Work/family/social functioning | Sheehan Disability scale as adjusted for baseline | 12 months after enrollment | |
Secondary | Global Anxiety Change | Patient-rated global anxiety change since enrollment | 3 months after enrollment | |
Secondary | Global Anxiety Change | Patient-rated global anxiety change since enrollment | 6 months after enrollment | |
Secondary | Global Anxiety Change | Patient-rated global anxiety change since enrollment | 9 months after enrollment | |
Secondary | Global Anxiety Change | Patient-rated global anxiety change since enrollment | 12 months after enrollment | |
Secondary | ED Utilization | Number of return visits to ED | 12 months prior to enrollment | |
Secondary | ED Utilization | Number of return visits to ED | 3 months after enrollment | |
Secondary | ED Utilization | Number of return visits to ED | 6 months after enrollment | |
Secondary | ED Utilization | Number of return visits to ED | 9 months after enrollment | |
Secondary | ED Utilization | Number of return visits to ED | 12 months after enrollment | |
Secondary | Adverse Cardiac Events | Number of major adverse cardiac events (death, myocardial infarction, revascularization) | 3 months after enrollment | |
Secondary | Adverse Cardiac Events | Number of major adverse cardiac events (death, myocardial infarction, revascularization) | 6 months after enrollment | |
Secondary | Adverse Cardiac Events | Number of major adverse cardiac events (death, myocardial infarction, revascularization) | 9 months after enrollment | |
Secondary | Adverse Cardiac Events | Number of major adverse cardiac events (death, myocardial infarction, revascularization) | 12 months after enrollment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03420456 -
Transcranial Pulse Near-Infrared Light in Generalized Anxiety Disorder: a Placebo-Controlled Study
|
N/A | |
Active, not recruiting |
NCT05530642 -
An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel
|
N/A | |
Withdrawn |
NCT02382224 -
Worry Exposure for Generalized Anxiety Disorder
|
N/A | |
Completed |
NCT02256566 -
Cognitive Training for Mood and Anxiety Disorders
|
N/A | |
Completed |
NCT02306356 -
Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical Setting
|
N/A | |
Completed |
NCT01958788 -
Testing Beliefs About Uncertainty in the Treatment of Generalized Anxiety Disorder
|
N/A | |
Completed |
NCT01681329 -
Cognitive-Behavioral Treatment and Interpretation Modification Training for Adults With Generalized Anxiety Disorder
|
N/A | |
Completed |
NCT01342120 -
PHARMO Institute Seroquel Safety Study
|
N/A | |
Completed |
NCT01337713 -
Efficacy of Massage Therapy in the Treatment of Generalized Anxiety Disorder (GAD)
|
N/A | |
Completed |
NCT01201967 -
A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients
|
Phase 4 | |
Completed |
NCT00961298 -
An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder
|
Phase 4 | |
Completed |
NCT01203293 -
Cognitive Behavioral Therapy (CBT) for Latinos With Generalized Anxiety Disorder in the General Medical Sector
|
Phase 1 | |
Completed |
NCT01971203 -
Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat
|
N/A | |
Completed |
NCT00711737 -
Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months
|
N/A | |
Completed |
NCT00744627 -
Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults.
|
Phase 3 | |
Terminated |
NCT01244711 -
Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines
|
Phase 4 | |
Completed |
NCT00515242 -
Therapeutic Massage for Generalized Anxiety Disorder
|
Phase 1/Phase 2 | |
Completed |
NCT00537615 -
An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers
|
Phase 1 | |
Completed |
NCT00525226 -
Evaluating the Effects of Stress in Pregnancy
|
N/A | |
Completed |
NCT00368745 -
Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use.
|
Phase 3 |